Search

Search Constraints

You searched for: Author/Creator Hvid, Malene

Search Results

1. Anti‐tumor necrosis factor treatment increases both the Th17 and Th22 T helper subsets in spondyloarthritis. Issue 12 (14th October 2019)

2. Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy. (August 2017)

3. Galectin‐3 interacts with PD‐1 and counteracts the PD‐1 pathway‐driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis. (30th December 2022)

4. OP0152 OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS DOES NOT SHOW SIGNS OF T-CELL EXHAUSTION, IN SPITE OF INCREASED EXPRESSION OF CO-INHIBITORY RECEPTORS. (June 2019)

5. SAT0006 T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3 (TIM-3) IS INCREASED IN ACTIVE RHEUMATOID ARTHRITIS AND ASSOCIATED WITH CLINICAL DISEASE ACTIVITY AND RADIOGRAPHIC PROGRESSION. (June 2019)

6. Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity. (4th July 2017)

8. The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression. Issue 1 (December 2016)

9. THU0018 ANTI-GALECTIN-9 ANTIBODY AS A NOVEL TREATMENT OPTION IN RHEUMATOID ARTHRITIS TARGETING PATHOGENIC FIBROBLAST-LIKE SYNOVIOCYTES. (June 2019)